We think that Insulet stock, a company best known for selling the Omnipod continuous insulin delivery system that caters to people with diabetes, currently is a better pick compared to ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for orthopedic and general surgery..
We think that Insulet stock, a company best known for selling the Omnipod continuous insulin delivery system that caters to people with diabetes, currently is a better pick compared to ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for orthopedic and general surgery..
Share this Article
Recommended